MEMO Monitor July 2026
- 4 days ago
- 7 min read
A word from the Co-founders
It feels like this year has been a challenge for just about everyone! Changes to Australia’s National Disability Insurance Scheme, cutbacks at public hospitals and of course global issues have affected all of us. In spite of this, MEMORehab has been pushing ahead, with a gradual increase the customer base and the start of an overseas expansion (see Trials in New Zealand).
We are also gathering feedback from Australian clinicians. We’re finding that MEMORehab is proving particularly useful in larger rehab units. Clinicians in these settings report receiving a lot of value from the MEMORehab annual license and are renewing without hesitation. They comment on the time saved in the preparation and organising of intervention materials. Some have found that using the program has been a great financial win for their service (see Generating Revenue in Public Hospitals). On the other hand, given the reductions in NDIS funding, several clinicians in private practice have reported that they are hesitant to take the plunge with an annual license. There have also been requests for a way to run the program without making a patient create an online account. You’ll see how we’ve addressed these issues by offering a new purchase option in Trial Licenses and by creating an off-line version of the program in MEMORehab Unplugged, respectively.
We’re very excited to note that the first research article has been published by an independent team on the MEMORehab’s feasibility and outcome. Find the original abstract in Peer-Reviewed, Independent Research.
We have recently completed a development round that will make the program more flexible and well able to provide service to our overseas customers. You can see these changes in Increasing Flexibility in Scheduling and Reminders
If you have any feedback or questions related to these changes, you can share them with us here: https://www.memorehab.com.au/contact
Participant Quote: MemoRehab has helped me to understand me, what happened to me, what is going on? …why I behaved a certain way. I liked the science parts...
Generating Revenue in Public Hospitals
In our last newsletter, https://www.memorehab.com.au/post/memo-monitor-july-2025 we offered advice on billing for the MEMORehab program. This was particularly aimed at those in private practice. Over the past year, we have gathered additional information on how MEMORehab can help teams in Public Hospitals to generate revenue for their service teams.
Activity Based Funding (ABF) is the way many hospitals calculate the distribution of funds. This means that the more patient contacts, the more a unit can receive from the central pool. MEMORehab is a great way to increase the number of contacts, particularly for neuropsychologists interested in providing rehabilitation. With each participant counted, the group-based approach supported in the program means that each hour of service can be counted up to six times!
As a result, centres in Queensland and New South Wales have reported to us that their MEMORehab-related ABF amounts to between $50,000 and $90,000 per year! Hence, an annual Organisation License is producing 13- 20 times its value.
Did you know? |
Our customer base: Of the Australian states, Queensland holds the highest number of MEMORehab licenses. Following a very rigorous review or our data storage processes, the Cyber Security Specialist at Metro North (Brisbane) gave us the stamp of approval. Clinicians in Western Australia, South Australia, Victoria and NSW are also currently using the program. We’d love to see MEMORehab servicing remote clients in Tasmania and the Northern Territory as well! |
Company Updates over the past year
Trials in New Zealand
We have been running free trials in New Zealand for the past several months. Feedback was obtained from 11 clinicians (Occupational Therapists, Neuropsychologists and Speech/Language Therapists) and 1 student. A total of 28 participants (aged 20-77) were involved; 1 with a CVA and 1 with a spinal cord injury and all the others had either a TBI or concussion. During this trial, 96% of patients who were considered appropriate for the program were successfully enrolled.
Main points:
MEMORehab works in NZ!
The majority of clinicians praised the program and recommended it for hospital, private practice, and university training clinic settings
Minor changes were requested, which have been addressed in the latest round of development.
Some therapists and patients had difficulty with or did not like the digital nature of the program/videoconferencing component. As a result, we now offer an off-line version as well (see MEMORehab Unplugged).
All the clinicians in the trial were paid by the ACC for the provision of the six guided MEMORehab sessions (whether these were run in person or over videoconferencing)
With sales commencing in NZ, we are about to start the next round of free trials in Canada in August.
Webinar
We have continued to run the APS-accredited CPD webinar entitled: Memory Disorders and Using MEMORehab for Cognitive Intervention. Given the positive feedback and good attendance, we are planning to renew this for another two years.
Contact us to register and win a free voucher for the APS-accredited CPD webinar described above (value: $55-$165 AUD). Winner will be announced in AUGUST. https://www.memorehab.com.au/contact |
New Partnerships
This year, our company has formed new collaborative partnerships with the companies that produce the Echo and SpaceCare platforms. Echo hosts content and mentoring opportunities. Its team also offers help in the production of short videos, which we have used for Linked In and other marketing efforts. SpaceCare allows clinicians to create and deliver content, activities and exercises to patients via AI assistance. You can find all our partners on our home page.
MEMOResearch
Two master’s student projects at Macquarie University under the supervision of Neuropsychologists, Heather Francis and Evelyn Harvey are underway to evaluate data from the MEMOResearch program. This is the program set up to collect outcome data as well as administer three of the computer-based training exercises.
Student Quote: I really enjoyed my time administering it with a young group of patients who all had surgical interventions for epilepsy. Found that they all got really involved in the process and enjoyed connecting with others going through a similar experience.
Trial license
Now available, a license that grants access to the program for a one-off, three-month period for seeing an unlimited number of patients. This allows clinicians to get a feel for how the program works and to see how many clients they can run through the program in a three-month period.
Note, participants will continue to have access to materials from the program for up to six weeks after the end-date of this type of license.
Programming Updates since July 2025
Increasing Flexibility in Scheduling and Reminders
As a result of our recent development round, there have been several improvements to the program.
You can now add participants that have previously been part of another group. We know this has been an ongoing issue, especially when participants are unable to finish the program and would like to try again at a later date.
The time over which you can spread your sessions is no longer limited to three months. You can choose to schedule sessions over an even longer period (limited only by the extent of your license).
You can now schedule a different group’s meeting time within 90 min of the start time of an originally scheduled meeting. You will get a warning to let you know about this potential scheduling conflict. One reason this change was requested was to allow clinicians to book sessions close together so that they could supervise students running the different sessions.
If you wish, you can now cancel the reminders being sent to participants (by either email or SMS). Do this using the toggle switch next to the participant’s name when you Edit or Add a New Group.
And, one can now enter international phone numbers to receive reminders.
A new edition of the Clinician’s Manual will soon be issued to include all these modifications.
MEMORehab Unplugged
In response to feedback that some patients are not able or willing to participate in a computerised version of the program, you can now request an offline version. This comes with clinician access to a revised set of slides, educational videos, quizzes, homework tasks and exercises. A set of instructions related to this off-line version is also provided. You can choose to use as many of the program’s resources as you like in your in-person sessions with a client. Contact us if you need this version. https://www.memorehab.com.au/contact
Did you know? |
 Testimonials on the Website No need to take it from us… listen to patients and clinicians talk about their experience with MEMORehab. https://www.memorehab.com.au/whatsnew |
Clinician Quote: My clients really enjoyed using the app and enjoyed the challenge of the exercises.
ACNpA presentation
Dr llana Hepner will be presenting at the Australian Clinical Neuropsychology Association meeting in Sydney in September: Which factors influence the completion of home-based generalisation tasks during a cognitive intervention provided by MEMORehab? Come along to find out more about how data from a digital rehabilitation tool can help us shape rehab efforts.
Peer-Reviewed, Independent Research
Daniel T Milligan et al. (2026) A phase 1 evaluation of the MEMORehab multi-modal online memory rehabilitation programme. Neuropsychological Rehabilitation https://doi.org/10.1080/09602011.2026.2631003
ABSTRACT:
MEMORehab is a telehealth-based evolution of a six-week memory rehabilitation programme, featuring weekly video-conferenced group sessions and asynchronous online activities. Its multi-modal format is intended to improve service access, convenience, flexibility, and engagement. The primary aim of this pilot non-randomized trial was to explore MEMORehab’s feasibility, acceptability, and user experience. Our secondary aim was to investigate its preliminary effectiveness for improving memory function. Ten participants with neurological diagnoses impacting memory joined MEMORehab. They and the five clinician facilitators were interviewed at baseline, weeks three and six, and six-week follow-up. Framework analysis helped characterize user experiences. Attrition, session attendance, and engagement with between-session tasks were used to evaluate feasibility. Preliminary efficacy measures included goal attainment scaling, memory performance, subjective memory, and strategy use. Change was assessed using repeated-measures ANOVAs. Participants regarded MEMORehab favourably, and attrition and session attendance supported feasibility. However, between-session engagement varied. We identified several factors enabling and impeding effective multi-modal online memory rehabilitation. Effect sizes suggested moderate-to-large improvements in goal attainment, learning, and delayed recall, and small-to-moderate improvements in subjective memory function and strategy use. This exploratory study offers promising support for multi-modal memory rehabilitation, and insights about challenges and opportunities to inform future intervention and trial designs.
Did you know? |
Grant funding may be available Several hospital teams have been awarded grants to purchase their first MEMORehab license to trial the program regarding feasibility and outcome (over the past year, these included submissions from The Royal Melbourne Hospital, The South Australia BIRCH team, Prince Charles Hospital in Brisbane and Austin Community Health). Some of these have taken the form of QI projects. Might such grants be available in your setting? |
